Literature DB >> 10441540

Therapeutic cloning: needs and prospects.

A Kind1, A Colman.   

Abstract

There has been widespread speculation regarding the possibility of reprogramming human somatic nuclei by transfer into oocytes. Stem cells derived from such reconstructed embryos could theoretically provide a source of autologous tissue for therapeutic transplantation. However the biological, technical and ethical hurdles which must be overcome before this can be realised are considerable. Here we review the background and prospects for such work.

Entities:  

Mesh:

Year:  1999        PMID: 10441540     DOI: 10.1006/scdb.1999.0277

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  5 in total

1.  Stem Cell Aging and Regenerative Medicine.

Authors:  Debojyoti De; Parimal Karmakar; Debalina Bhattacharya
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Toward beta cell replacement for diabetes.

Authors:  Bjarki Johannesson; Lina Sui; Donald O Freytes; Remi J Creusot; Dieter Egli
Journal:  EMBO J       Date:  2015-03-01       Impact factor: 11.598

3.  Reprogramming within hours following nuclear transfer into mouse but not human zygotes.

Authors:  Dieter Egli; Alice E Chen; Genevieve Saphier; Justin Ichida; Claire Fitzgerald; Kathryn J Go; Nicole Acevedo; Jay Patel; Manfred Baetscher; William G Kearns; Robin Goland; Rudolph L Leibel; Douglas A Melton; Kevin Eggan
Journal:  Nat Commun       Date:  2011-10-04       Impact factor: 14.919

Review 4.  Current status and prospects for gene and cell therapeutics for type 1 diabetes mellitus.

Authors:  Nick Giannoukakis; Massimo Trucco
Journal:  Rev Endocr Metab Disord       Date:  2003-12       Impact factor: 9.306

5.  β-Cell Replacement in Mice Using Human Type 1 Diabetes Nuclear Transfer Embryonic Stem Cells.

Authors:  Lina Sui; Nichole Danzl; Sean R Campbell; Ryan Viola; Damian Williams; Yuan Xing; Yong Wang; Neil Phillips; Greg Poffenberger; Bjarki Johannesson; Jose Oberholzer; Alvin C Powers; Rudolph L Leibel; Xiaojuan Chen; Megan Sykes; Dieter Egli
Journal:  Diabetes       Date:  2017-09-20       Impact factor: 9.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.